{"id":42324,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/google-and-stanford-license-agreement.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"google-and-stanford-license-agreement","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/operations\/google-and-stanford-license-agreement.html","title":{"rendered":"Google and Stanford License Agreement"},"content":{"rendered":"
 <\/font><\/p> 
Exclusive License <\/font><\/p> 
S01-027, S01-028: IO <\/font><\/p> 
7\/2\/01 <\/font><\/p> 
 <\/font><\/p> 
The offer contained herein is valid for a license that is fully executed by July 30, 2001 and is subject to change without notice thereafter. STANFORD is under no\nobligation to grant a license or any other rights during or beyond the expiration date. <\/font><\/p> 
 <\/font><\/p> 
AGREEMENT <\/b><\/font><\/p> 
 <\/font><\/p> 
Effective as of July 2, 2001\n(\u0093Effective Date\u0094), THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California (\u0093STANFORD\u0094), and Google Inc., a California corporation having a\nprincipal place of business at 2400 Bayshore Pkwy., Mountain View, CA 94043 (\u0093LICENSEE\u0094), agree as follows: <\/font><\/p> 
 <\/font><\/p> 
1. BACKGROUND <\/u><\/b><\/font><\/p> 
 <\/font><\/p>\n\n<\/pre>\n\n\n
1.1<\/font><\/td>\nSTANFORD and LICENSEE are parties to a License Agreement effective December 1, 1998 (\u0093Original Agreement\u0094) for \u0093Improved Text Searching in Hypertext Systems\u0094 as
\ndescribed in Stanford Docket S96-213. LICENSEE is exercising its Option to acquire an exclusive license to STANFORD\u0092s rights in Licensed Patent(s) filed based on technology identified in Appendix A of the Original Agreement which was conceived
\nsolely by Lawrence Page and\/or Sergey Brin in the course of Stanford responsibilities and reduced to practice by Mr. Page or Mr. Brin in the course of their affiliation with LICENSEE. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
1.2<\/font><\/td>\nSTANFORD desires to have the Licensed Patent(s) perfected and marketed at the earliest possible time in order that products resulting therefrom may be available for public use and
\nbenefit. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
1.3<\/font><\/td>\nLICENSEE desires an exclusive license to Stanford\u0092s rights under said Licensed Patent(s) to develop, manufacture, use, and sell Licensed Product(s) in the field of use of
\nInternet search applications. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
2. DEFINITIONS
\n<\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
2.1<\/font><\/td>\n\u0093Licensed Patent(s)\u0094 means any Letters Patent issued upon STANFORD and LICENSEE jointly owned U.S. Patent Applications, <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(a)<\/font><\/td>\nSerial Number 09\/521,996, filed 03\/09\/2000, based on Stanford Docket #S01-028 \u0093Information Extraction from a Database\u0094; and <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(b)<\/font><\/td>\nAny patent applications based on Stanford Docket #S01-027 \u0093Background Surfing\u0094 <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
any foreign patents corresponding thereto, and\/or any divisions, continuations, continuations-in-part or reissue thereof.
\n<\/font><\/p>\n
 <\/font><\/p>\n\n\n
2.2<\/font><\/td>\n\u0093Licensed Product(s)\u0094 means any product or part thereof in the Licensed Field of Use, the manufacture, use, or sale of which: <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(a)<\/font><\/td>\nIs covered by a valid claim of an issued, unexpired Licensed Patent(s). A claim of an issued, unexpired Licensed Patent(s) shall be presumed to be valid unless and until it has been
\nheld to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken; or <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(b)<\/font><\/td>\nIs covered by any claim being prosecuted in a pending application directed to the Licensed Patent(s). <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
2.3<\/font><\/td>\n\u0093Licensed Field of Use\u0094 means Internet Applications. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
2.4<\/font><\/td>\n\u0093Licensed Territory\u0094 means worldwide. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
2.5<\/font><\/td>\n\u0093Exclusive\u0094 means that, subject to Article 4, STANFORD shall not grant further licenses in the Licensed Territory in the Licensed Field of Use. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
2.6<\/font><\/td>\n\u0093Patent Sublicense\u0094 means any sublicense of Licensed Patent(s) granted by LICENSEE to a third party to allow that third party to make, use, and sell its own Licensed
\nProducts without LICENSEE providing products or services. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
3. GRANT<\/u> <\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
3.1<\/font><\/td>\nSTANFORD hereby grants and LICENSEE hereby accepts a license in the Licensed Field of Use to make, use, and sell Licensed Product(s) in the Licensed Territory.
\n<\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
3.2<\/font><\/td>\nSaid license is Exclusive, including the right to grant Patent Sublicenses pursuant to Article 12, in the Licensed Field of Use for a term commencing as of March 30, 2001, and
\nending on the first to occur of the following: <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(a)<\/font><\/td>\n8 years from the Effective Date; or <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(b)<\/font><\/td>\n5 years from the issue date of the last to issue of Licensed Patent(s). <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
Thereafter, said license shall be nonexclusive until expiration of the last to expire of Licensed Patent(s). <\/font><\/p>\n
 <\/font><\/p>\n\n\n
3.3<\/font><\/td>\nSTANFORD shall have the right to practice the Licensed Patent(s) for its own bona fide research, including sponsored research and collaborations. STANFORD shall have the right to
\npublish any information included in the Licensed Patent(s). <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
4. GOVERNMENT RIGHTS<\/u> <\/b><\/font><\/p>\n
 <\/font><\/p>\n
If there has been government
\nsponsorship, this Agreement is subject to all of the terms and conditions of Title 35 United States Code Sections 200 through 204, including an obligation that Licensed Product(s) sold or produced in the United States be \u0093manufactured
\nsubstantially in the United States,\u0094 and LICENSEE agrees to take all reasonable action necessary on its part as licensee to enable STANFORD to satisfy its obligation thereunder, relating to Licensed Patent(s). <\/font><\/p>\n
 <\/font><\/p>\n
-2- <\/font><\/p>\n
5. DILIGENCE <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
5.1<\/font><\/td>\nAs an inducement to STANFORD to enter into this Agreement, LICENSEE agrees to use all reasonable efforts and diligence to proceed with the development, manufacture, and sale or
\nlease of Licensed Product(s) and to diligently develop markets for the Licensed Product(s). Unless LICENSEE has a Licensed Product(s) available for commercial sale prior to 5 years from the Effective Date, LICENSEE agrees that STANFORD may terminate
\nthis Agreement. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
5.2<\/font><\/td>\nProgress Report<\/u> – On or before August 1 of each year until LICENSEE markets a Licensed Product(s), LICENSEE shall make a written annual report to STANFORD covering the
\npreceding year ending June 30, regarding the progress of LICENSEE toward commercial use of Licensed Product(s). Such report shall include, as a minimum, information sufficient to enable STANFORD to satisfy reporting requirements of the U.S.
\nGovernment and for STANFORD to ascertain progress by LICENSEE toward meeting the diligence requirements of this Article 5. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
6. ROYALTIES <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
6.1<\/font><\/td>\nIn consideration of the rights granted it by this Agreement, LICENSEE agrees to make payments to STANFORD as set forth in this Article 6. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
6.2<\/font><\/td>\nLICENSEE agrees to pay to STANFORD a noncreditable, nonrefundable license royalty of Twenty-five Thousand Dollars ($25,000) for Stanford Docket # S01-028 upon signing this
\nAgreement. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
6.3<\/font><\/td>\nWithin 30 days after issuance of any Letters Patent for U.S. Patent Application 10\/408,784 filed on 04\/08\/2003 based on Stanford Docket # S01-027, LICENSEE shall pay STANFORD a
\nnoncreditable, nonrefundable license royalty of Twenty-five Thousand Dollars ($25,000). <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
6.4<\/font><\/td>\nLICENSEE shall pay for all costs incurred in connection with the preparation, filing, prosecution and maintenance of Licensed Patent(s). The filing, prosecution, and maintenance of
\nall Licensed Patent(s) shall be the primary responsibility of LICENSEE; provided, however, STANFORD will have reasonable opportunities to participate in decision making relative to such filing, prosecution, and maintenance, and LICENSEE will use its
\nbest efforts to incorporate STANFORD\u0092S reasonable suggestions regarding said prosecution. LICENSEE patent counsel will directly notify both parties of any actions relating to said prosecution. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
7. NEGATION OF WARRANTIES <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
7.1<\/font><\/td>\nNothing in this Agreement is or shall be construed as: <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(a)<\/font><\/td>\nA warranty or representation by STANFORD as to the validity or scope of any Licensed Patent(s); <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
-3- <\/font><\/p>\n\n\n
 <\/font><\/td>\n(b)<\/font><\/td>\nA warranty or representation that anything made, used, sold, or otherwise disposed of under any license granted in this Agreement is or will be free from infringement of patents,
\ncopyrights, and other rights of third parties; <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(c)<\/font><\/td>\nAn obligation to bring or prosecute actions or suits against third parties for infringement, except to the extent and in the circumstances described in Article 11;
\n<\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(d)<\/font><\/td>\nGranting by implication, estoppel, or otherwise any licenses or rights under patents or other rights of STANFORD or other persons other than Licensed Patent(s), regardless of
\nwhether such patents or other rights are dominant or subordinate to any Licensed Patent(s); or <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(e)<\/font><\/td>\nAn obligation to furnish any technology or technological information. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
7.2<\/font><\/td>\nExcept as expressly set forth in this Agreement, STANFORD MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED
\nWARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE LICENSED PRODUCT(S) WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER RIGHTS OR ANY OTHER EXPRESS OR IMPLIED WARRANTIES. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
8. INDEMNITY <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
8.1<\/font><\/td>\nLICENSEE agrees to indemnify, hold harmless, and defend STANFORD, UCSF-Stanford Health Care and Stanford Health Services and their respective trustees, officers, employees,
\nstudents, and agents against any and all claims for death, illness, personal injury, property damage, and improper business practices arising out of the manufacture, use, sale, or other disposition of Licensed Patent(s) or Licensed Product(s) by
\nLICENSEE or sublicensee(s), or their customers. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
8.2<\/font><\/td>\nSTANFORD shall not be liable for any indirect, special, consequential or other damages whatsoever, whether grounded in tort (including negligence), strict liability, contract or
\notherwise. STANFORD shall not have any responsibilities or liabilities whatsoever with respect to Licensed Products(s). <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
8.3<\/font><\/td>\nLICENSEE shall at all times comply, through insurance or self-insurance, with all statutory workers\u0092 compensation and employers\u0092 liability requirements covering any and
\nall employees with respect to activities performed under this Agreement. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
-4- <\/font><\/p>\n\n\n
8.4<\/font><\/td>\nIn addition to the foregoing, LICENSEE shall maintain, during the term of this Agreement, Comprehensive General Liability Insurance, including Products Liability Insurance, with
\nreputable and financially secure insurance carrier(s) to cover the activities of LICENSEE and its sublicensee(s). Such insurance shall provide minimum limits of liability of $1 Million and shall include STANFORD, UCSF-Stanford Health Care, Stanford
\nHealth Services, their trustees, directors, officers, employees, students, and agents as additional insureds. Such insurance shall be written to cover claims incurred, discovered, manifested, or made during or after the expiration of this Agreement
\nand should be placed with carriers with ratings of at least A- as rated by A.M. Best. Within 15 days of the Effective Date of this Agreement, LICENSEE shall furnish a Certificate of Insurance evidencing primary coverage and additional insured
\nrequirements and requiring thirty (30) days prior written notice of cancellation or material change to STANFORD. LICENSEE shall advise STANFORD, in writing, that it maintains excess liability coverage (following form) over primary insurance for at
\nleast the minimum limits set forth above. All such insurance of LICENSEE shall be primary coverage; insurance of STANFORD, UCSF-Stanford Health Care, and Stanford Health Services shall be excess and noncontributory. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
9. MARKING <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n
Prior to the issuance of Licensed Patent(s), LICENSEE agrees to mark Licensed Products (or their containers or labels) made, sold, or
\notherwise disposed of by it under the license granted in this Agreement with the words \u0093Patent Pending,\u0094 and following the issuance of one or more patents, with the numbers of the Licensed Patent(s). <\/font><\/p>\n
 <\/font><\/p>\n
10. STANFORD NAMES AND MARKS <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n
LICENSEE agrees not to identify STANFORD in any promotional advertising or other promotional
\nmaterials to be disseminated to the public or any portion thereof or to use the name of any STANFORD faculty member, employee, or student or any trademark, service mark, trade name, or symbol of STANFORD, Stanford Health Services or UCSF-Stanford
\nHealth Care, or that is associated with any of them, without STANFORD\u0092s prior written consent. Any use of STANFORD\u0092s name shall be limited to statements of fact and shall not imply endorsement of LICENSEE\u0092s products or services.<\/p>\n
<\/font><\/p>\n
 <\/font><\/p>\n
11. INFRINGEMENT BY OTHERS: PROTECTION OF PATENTS <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
11.1<\/font><\/td>\nLICENSEE shall promptly inform STANFORD of any suspected infringement of any Licensed Patent(s) by a third party. During the Exclusive period of this Agreement, STANFORD and
\nLICENSEE each shall have the right to institute an action for infringement of the Licensed Patent(s) in the Licensed Field of Use against such third party in accordance with the following: <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(a)<\/font><\/td>\n\n
If STANFORD and LICENSEE agree to institute suit jointly, the suit shall be brought in both their names, the out-of-pocket costs thereof shall be borne equally, and
\nany recovery or settlement shall be shared equally. LICENSEE and STANFORD shall agree to the manner in which they <\/font>\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
-5- <\/font><\/p>\n\n\n
 <\/font><\/td>\n\n
\nshall exercise control over such action. STANFORD may, if it so desires, also be represented by separate counsel of its own selection, the fees for which
\ncounsel shall be paid by STANFORD; <\/font><\/p>\n<\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(b)<\/font><\/td>\nIn the absence of agreement to institute a suit jointly, STANFORD may institute suit, and, at its option, join LICENSEE as a plaintiff. If STANFORD decides to institute suit, then
\nit shall notify LICENSEE in writing. LICENSEE\u0092S failure to notify STANFORD in writing, within fifteen (15) days after the date of the notice, that it will join in enforcing the patent pursuant to the provisions hereof, shall be and be deemed
\nconclusively to be LICENSEE\u0092S assignment to STANFORD of all rights, causes of action, and damages resulting from any such alleged infringement. STANFORD shall bear the entire cost of such litigation and shall be entitled to retain the entire
\namount of any recovery or settlement; and <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(c)<\/font><\/td>\nIn the absence of agreement to institute a suit jointly and if STANFORD notifies LICENSEE that it has decided not to join in or institute a suit, as provided in (a) or (b) above,
\nLICENSEE may institute suit. LICENSEE shall bear the entire cost of such litigation, including expenses incurred by STANFORD., in the reasonable opinion of LICENSEE\u0092S and STANFORD\u0092S respective counsel, STANFORD should be a named party to
\nany such suit for standing purposes, LICENSEE may join STANFORD as a party, provided, however, that (i) STANFORD shall not be the first named party in any such action, (ii) the pleadings and any public statements about the action shall state that
\nthe action is being pursued by LICENSEE and that LICENSEE has the right to join STANFORD as a party; and (iii) LICENSEE shall keep STANFORD reasonably apprised of all developments in any such action. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
Any recovery in excess of litigation costs will be shared with STANFORD as
\nmutually agreed upon prior to the initiation of litigation. LICENSEE and STANFORD agree to negotiate in good faith an appropriate compensation to STANFORD for any non-cash settlement or non-cash cross-license. <\/font><\/p>\n
 <\/font><\/p>\n\n\n
11.2<\/font><\/td>\nShould either STANFORD or LICENSEE commence a suit under the provisions of Paragraph 11.1 and thereafter elect to abandon the same, it shall give timely notice to the other party
\nwho may, if it so desires, continue prosecution of such suit, provided, however, that the sharing of expenses and any recovery in such suit shall be as agreed upon between STANFORD and LICENSEE. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
12. SUBLICENSE(S) <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
12.1<\/font><\/td>\nLICENSEE may grant Patent Sublicense(s) in the Licensed Field of Use during the Exclusive period. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
12.2<\/font><\/td>\nIf LICENSEE is unable or unwilling to serve or develop a potential market or market territory for which there is a willing sublicensee(s), LICENSEE will, at STANFORD\u0092s request,
\nnegotiate in good faith a Patent Sublicense(s) hereunder. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
-6- <\/font><\/p>\n\n\n
12.3<\/font><\/td>\nAny Patent Sublicense(s) granted by LICENSEE under this Agreement shall be subject and subordinate to terms and conditions of this Agreement, except Patent Sublicense terms and
\nconditions shall reflect that any sublicensee(s) shall not further sublicense. Any such sublicense(s) also shall expressly include the provisions of Articles 7 and 8 for the benefit of STANFORD and provide for the transfer of all obligations,
\nincluding the payment of royalties specified in such sublicense(s), to STANFORD or its designee., in the event that this Agreement is terminated.<\/b> <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
12.4<\/font><\/td>\nPrior to issuing any Patent Sublicense(s), LICENSEE agrees to negotiate with STANFORD to reach a mutually satisfactory agreement and reasonable sharing of Patent Sublicensing income
\npayable to STANFORD for any such Patent Sublicense(s) executed during the exclusive period. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
12.5<\/font><\/td>\nLICENSEE agrees to provide STANFORD a copy of any Patent Sublicense granted pursuant to this Article 12. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
13. TERMINATION <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
13.1<\/font><\/td>\nLICENSEE may terminate this Agreement by giving STANFORD notice in writing at least thirty (30) days in advance of the effective date of termination selected by LICENSEE.
\n<\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
13.2<\/font><\/td>\nSTANFORD may terminate this Agreement if LICENSEE: <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(a)<\/font><\/td>\nIs in default in payment of royalty or providing of reports; <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(b)<\/font><\/td>\nIs in breach of any provision hereof; or <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(c)<\/font><\/td>\nProvides any false report; <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
and LICENSEE fails to remedy any such default, breach, or false report within thirty (30) days after written notice thereof by STANFORD. <\/font><\/p>\n
 <\/font><\/p>\n\n\n
13.3<\/font><\/td>\nSurviving any termination or expiration are: <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(a)<\/font><\/td>\nLICENSEE\u0092S obligation to pay royalties accrued or accruable; <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(b)<\/font><\/td>\nAny cause of action or claim of LICENSEE or STANFORD, accrued or to accrue, because of any breach or default by the other party; and <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
 <\/font><\/td>\n(c)<\/font><\/td>\nThe provisions of Articles 7, and 8 and any other provisions that by their nature are intended to survive. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
14. ASSIGNMENT <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n
This Agreement may not be assigned. <\/font><\/p>\n
 <\/font><\/p>\n
-7- <\/font><\/p>\n
15. ARBITRATION <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n\n\n
15.1<\/font><\/td>\nAny controversy arising under or related to this Agreement, and any disputed claim by either party against the other under this Agreement excluding any dispute relating to patent
\nvalidity or infringement arising under this Agreement, shall be settled by arbitration in accordance with the Licensing Agreement Arbitration Rules of the American Arbitration Association. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
15.2<\/font><\/td>\nUpon request by either party, arbitration will be by a third party arbitrator mutually agreed upon in writing by LICENSEE and STANFORD within thirty (30) days of such arbitration
\nrequest. Judgement upon the award rendered by the arbitrator shall be final and nonappealable and may be entered in any court having jurisdiction thereof. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
15.3<\/font><\/td>\nThe parties shall be entitled to discovery in like manner as if the arbitration were a civil suit in the California Superior Court. The Arbitrator may limit the scope, time and\/or
\nissues involved in discovery. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n\n\n
15.4<\/font><\/td>\nAny arbitration shall be held at Stanford, California, unless the parties hereto mutually agree in writing to another place. <\/font><\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
16. NOTICES <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n
All notices under this Agreement shall be deemed to have been fully given when done in writing and deposited in the United States mail,
\nregistered or certified, and addressed as follows: <\/font><\/p>\n
 <\/font><\/p>\n\n\n\n\n\n\n\n\n\n\n
<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n
To STANFORD:<\/font><\/p>\n<\/td>\n
  <\/font><\/td>\n\n
To LICENSEE:<\/font><\/p>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
\n
Office of Technology Licensing<\/font><\/p>\n<\/td>\n
  <\/font><\/td>\n\n
Google Inc.<\/font><\/p>\n<\/td>\n<\/tr>\n
\n
Stanford University<\/font><\/p>\n<\/td>\n
  <\/font><\/td>\n\n
2400 Bayshore Pkwy<\/font><\/p>\n<\/td>\n<\/tr>\n
\n
900 Welch Road, Suite 350<\/font><\/p>\n<\/td>\n
  <\/font><\/td>\n\n
Mountain View CA 94043<\/font><\/p>\n<\/td>\n<\/tr>\n
\n
Palo Alto, CA 94304-1850<\/font><\/p>\n<\/td>\n
  <\/font><\/td>\n\n
________________________________________<\/font><\/p>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
\n
Attention: Director<\/font><\/p>\n<\/td>\n
  <\/font><\/td>\n\n
Attention: Legal Dept.<\/font><\/p>\n<\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
Either party may change its address
\nupon written notice to the other party. <\/font><\/p>\n
 <\/font><\/p>\n
17. WAIVER <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n
None of the terms of this Agreement can be waived except by the written consent of the
\nparty waiving compliance. <\/font><\/p>\n
 <\/font><\/p>\n
-8- <\/font><\/p>\n
18. APPLICABLE LAW <\/u><\/b><\/font><\/p>\n
 <\/font><\/p>\n
This Agreement shall be governed by the laws of the State of California applicable to agreements negotiated, executed and performed wholly
\nwithin California. <\/font><\/p>\n
 <\/font><\/p>\n
IN WITNESS WHEREOF, the parties hereto have executed this
\nAgreement in duplicate originals by their duly authorized officers or representatives. <\/font><\/p>\n
 <\/font><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
THE BOARD OF TRUSTEES OF THE
LELAND STANFORD JUNIOR UNIVERSITY<\/font><\/td>\n		 <\/font><\/td>\nLICENSEE<\/font><\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n
Signature<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
\/s\/ Katharine Ku<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
Signature<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
\/s\/ Sergey Brin<\/font><\/p>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n
Name<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
Katharine Ku<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
Name<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
Sergey Brin<\/font><\/p>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n
Title<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
Director Technology Licensing<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
Title<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
President<\/font><\/p>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n
Date<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
August 7, 2001<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
Date<\/font><\/p>\n<\/td>\n
 <\/font><\/td>\n\n
7\/30\/01<\/font><\/p>\n<\/td>\n<\/tr>\n<\/table>\n
 <\/font><\/p>\n
-9- <\/font><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[7664],"corporate_contracts_industries":[9510],"corporate_contracts_types":[9613,9616],"class_list":["post-42324","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-google-inc","corporate_contracts_industries-technology__programming","corporate_contracts_types-operations","corporate_contracts_types-operations__ip"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/42324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=42324"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=42324"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=42324"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=42324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}